• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.[勘误] lncRNA EGFR-AS1 过表达与非小细胞肺癌不良预后相关，并促进其化疗耐药。
Int J Oncol. 2019 Jul;55(1):340. doi: 10.3892/ijo.2019.4686. Epub 2019 Jan 14.
2
[Corrigendum] CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.[勘误] CHD1L与肝内胆管癌的不良预后相关，并促进其增殖和转移。
Oncol Rep. 2019 Oct;42(4):1631. doi: 10.3892/or.2019.7262. Epub 2019 Aug 5.
3
[Corrigendum] CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.勘误：CENPE 促进肺腺癌增殖，并且直接受到 FOXM1 的调控。
Int J Oncol. 2019 Dec;55(6):1397. doi: 10.3892/ijo.2019.4872. Epub 2019 Sep 6.
4
[Corrigendum] miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.[勘误] miR-122通过抑制叉头框O3促进肾透明细胞癌的增殖和侵袭。
Int J Oncol. 2019 Apr;54(4):1496. doi: 10.3892/ijo.2019.4694. Epub 2019 Jan 23.
5
[Corrigendum] HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways.[勘误] HMGB1 通过激活巨噬细胞中的 AIM2 炎性小体，并通过 TLR2、TLR4 和 RAGE/NF-κB 信号通路诱导 M1 巨噬细胞极化，参与 LPS 诱导的急性肺损伤。
Int J Mol Med. 2020 May;45(5):1628. doi: 10.3892/ijmm.2020.4530. Epub 2020 Mar 6.
6
[Corrigendum] Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV.[勘误]SENP1的过表达降低骨肉瘤干细胞的干性能力并增加其对HSVtk/GCV的敏感性。
Int J Oncol. 2019 Jun;54(6):2258. doi: 10.3892/ijo.2019.4752. Epub 2019 Mar 18.
7
[Corrigendum] Heat shock protein 90/Akt pathway participates in the cardioprotective effect of exogenous hydrogen sulfide against high glucose‑induced injury to H9c2 cells.[勘误] 热休克蛋白 90/akt 通路参与外源性硫化氢对高糖诱导 H9c2 细胞损伤的心脏保护作用。
Int J Mol Med. 2018 Sep;42(3):1765. doi: 10.3892/ijmm.2018.3708. Epub 2018 May 29.
8
[Corrigendum] NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.[勘误] NORAD通过miR-422a调控非小细胞肺癌细胞的上皮-间质转化
Mol Med Rep. 2021 Jul;24(1). doi: 10.3892/mmr.2021.12178. Epub 2021 Jun 3.
9
[Corrigendum] Protective effect of angiotensin‑(1‑7) against hyperglycaemia‑induced injury in H9c2 cardiomyoblast cells via the PI3K̸Akt signaling pathway.[勘误]血管紧张素-(1-7)通过 PI3K̸Akt 信号通路对高糖诱导的 H9c2 心肌细胞损伤的保护作用。
Int J Mol Med. 2018 Aug;42(2):1199. doi: 10.3892/ijmm.2018.3657. Epub 2018 May 7.
10
[Corrigendum] A 44‑gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.[勘误] 用于预测透明细胞肾细胞癌预后的44基因集。
Int J Mol Med. 2019 May;43(5):2261. doi: 10.3892/ijmm.2019.4138. Epub 2019 Mar 19.

[勘误] lncRNA EGFR-AS1 过表达与非小细胞肺癌不良预后相关，并促进其化疗耐药。

[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.

机构信息

Department of Cardiovascular Medicine, Jiangxi Chest Hospital, Nanchang 330006, P.R. China.

Department of Oncology, Jiangxi Cancer Hospital, Nanchang 330029, P.R. China.

出版信息

Int J Oncol. 2019 Jul;55(1):340. doi: 10.3892/ijo.2019.4686. Epub 2019 Jan 14.

DOI:10.3892/ijo.2019.4686
PMID:30664200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6561623/
Abstract

After the publication of the article, the authors have realized that the affiliation presented for the joint co‑author listed on the paper (Jian‑Ren Tu) was incorrect. The correct author list (and affiliations) should therefore have been published as follows: Yu‑Hua Xu1*, Jian‑Ren Tu2*, Tian‑Tian Zhao3, Shi‑Guang Xie3 and Sheng‑Bo Tang4. 1Department of Cardiovascular Medicine, Jiangxi Chest Hospital, Nanchang, Jiangxi 330006; 2Department of Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029; Departments of 3Respiratory Medicine and 4Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China. *Contributed equally. The authors apologize for their oversight, and for any inconvenience that this has caused. [the original article was published in International Journal of Oncology 54: 295‑305, 2019; DOI: 10.3892/ijo.2018.4629].

摘要

文章发表后，作者发现论文中列出的联合共同作者（涂建成）的所属单位不正确。正确的作者列表（及所属单位）应为：徐宇华 1*，涂建成 2*，赵田田 3，谢世广 3，汤胜波 4。1. 江西省胸科医院心血管医学科，南昌 330006；2. 江西省肿瘤医院肿瘤内科，南昌 330029；3. 南昌大学第一附属医院呼吸内科和 4. 医学肿瘤科，南昌 330006，中国。* 共同贡献。作者对他们的疏忽以及由此造成的任何不便表示歉意。[原始文章发表于国际肿瘤学杂志 54: 295-305, 2019; DOI: 10.3892/ijo.2018.4629]。